Delta-tocotrienol from annatto decreased biomarkers associated with fatty liver, suggests a published clinical study in patients diagnosed with non-alcoholic fatty liver disease (NAFLD).
A recent study conducted at the Armed Forces Institute of Pathology in Pakistan, and published in the Turkish Journal of Gastroenterology, adds new data to a growing body of evidence that shows tocotrienol benefits for the liver.